79
Participants
Start Date
December 14, 2018
Primary Completion Date
June 15, 2025
Study Completion Date
February 15, 2029
Atezolizumab
Atezolizumab after adjuvant radio-chemotherapy for the treatment of patients with muscle-invasive bladder cancer not eligible for radical cystectomy
Gustave Roussy, Villejuif
Institut Bergonie, Bordeaux
Centre Jean Perrin, Clermont-Ferrand
Centre Georges Francois Leclerc, Dijon
Centre Oscar Lambret, Lille
Icm Val D'Aurelle, Montpellier
Centre Antoine Lacassagne, Nice
Hopital Saint Louis, Paris
Hôpital Pitie Salpetriere, Paris
Chu Lyon Sud, Pierre-Bénite
INSTITUT de CANCEROLOGIE DE L'OUEST - site René Gauducheau, Saint-Herblain
Centre Azureen de Cancerologie, Mougins
Roche Pharma AG
INDUSTRY
UNICANCER
OTHER